Industry News
Share your love
Théa Obtains Sepofarsen and Ultevursen from ProQR
ProQR Therapeutics and Laboratoires Théa have reached an agreement through which ProQR will transfer its advanced ophthalmic assets, sepofarsen and ultevursen, to Théa. Under the terms of the agreement, ProQR will secure an initial payment totaling €12.5 million ($13.7 million).…
Oyster Pharma’s Tyrvaya Is Widely Available to Patients
Oyster Point Pharma announced the expansion of patient access to its nasal spray medication for dry eye disease, Tyrvaya (varenicline solution), and provided an update In an update on Tyrvaya’s US commercial success in the US. According to Oyster Point,…
The Biggest Challenges in Ophthalmology Today
A recent survey conducted by OBN on LinkedIn asked participants to identify the most pressing challenge facing the ophthalmology field today. The poll revealed that nearly half of the respondents believe patient access to care is the primary issue, followed…
Therapeutic Contact Lenses Market to Grow Significantly
A recent report by Future Market Insights has made some exciting predictions about the therapeutic contact lenses market. The report states that the market is set to experience significant growth in the next decade, rising from an estimated USD 12,595.3…
Micro Labs Launches World’s First Triple-Drug for Glaucoma
Micro Labs, based in Bengaluru, announced the launch of Trisopt, the world’s first fixed-dose combination (FDC) to include Brimonidine, Timolol, and Brinzolamide in an ophthalmic suspension, designed specifically for the management of glaucoma. The drug is manufactured within Micro Labs’…
Global Pharma Healthcare Recalls EzriCare Eye Drops
Global Pharma Healthcare is recalling its Artificial Tears Lubricant Eye Drops due to potential contamination. The recall affects all lots within expiry and covers products distributed by EzriCare LLC and Delsam Pharma. This comes after the CDC informed the FDA…
FDA Warns of Delsam Pharma’s Artificial Eye Ointment
The FDA has issued a warning to consumers and healthcare professionals not to purchase or use Delsam Pharma’s Artificial Eye Ointment due to potential bacterial contamination. This eye oinment is an over-the-counter product, intended to be sterile and produced by…
Exclusive Interview with Dr. Stanley Windsor at Rayner
● Download RayPRO on App Store and Google Play.● Listen to Peer2Peer on Spotify, Apple Podcasts, Google Podcasts, and Youtube. Question 1: Can you provide an overview of Rayner’s PayPRO and Peer2Peer platforms?Dr. Stanley Windsor, Digital Innovation Manager: Thank you very much for…
Common Eye Conditions – Names of Eye Diseases List
In our daily lives, we usually take our eyesight for granted and avoid going to see a professional regularly. Our eyesight is one of the most valuable assets that we have. There are hundreds of different eye diseases and conditions.…
Novo Nordisk Weight Loss Drugs Linked to Higher NAION Risk
A recent study led by investigators from Mass Eye and Ear has found a concerning association between the use of semaglutide, prescribed for diabetes and weight loss under brand names Ozempic and Wegovy, developed by Novo Nordisk, and an increased…